Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
Not Applicable
Completed
- Conditions
- Schizoaffective DisorderSchizophrenia
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2005-09-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 80
- Registration Number
- NCT00179231
Prevention and Treatment of Hemodialysis Vascular Access Malfunction
Phase 2
Withdrawn
- Conditions
- End-Stage Renal Disease
- Interventions
- Procedure: angioplastyProcedure: surgery
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-05-25
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00179192
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Hepatocellular Research Registry
- Conditions
- Hepatocytes
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 200
- Registration Number
- NCT00178893
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 20
- Registration Number
- NCT00179257
Acoustical Properties of Speech as Indicators of Suicidal Risk
Completed
- Conditions
- Depression
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-11-23
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 124
- Registration Number
- NCT00178906
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee
Phase 2
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Dietary Supplement: Nepro nutritional supplement
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 352
- Registration Number
- NCT00179153
- Locations
- 🇺🇸
National Kidney Foundation, Nashville, Tennessee, United States
Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2006-08-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 42
- Registration Number
- NCT00179101
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Phase 2
Completed
- Conditions
- Mycosis FungoidesCutaneous T-cell LymphomaSezary Syndrome
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 4
- Registration Number
- NCT00178841
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Vanderbilt University Spasticity Management Program Evaluation Plan
Phase 4
Completed
- Conditions
- Spasticity
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2007-08-20
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 20
- Registration Number
- NCT00179114
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
Completed
- Conditions
- Hematopoietic Stem Cell TransplantationGraft vs Host Disease
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-12-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 100
- Registration Number
- NCT00179049
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath